sj-pdf-2-sci-10.1177_00368504231220765 - Supplemental material for A puzzling case report of well-differentiated neuroendocrine tumor mixed with gastric adenocarcinoma of the fundic gland type associated with autoimmune gastritis

Supplemental material, sj-pdf-2-sci-10.1177_00368504231220765 for A puzzling case report of well-differentiated neuroendocrine tumor mixed with gastric adenocarcinoma of the fundic gland type associated with autoimmune gastritis by Zheng Wang, Weixun Zhou, Jingnan Li, Wenlong Wen, Zhiyong Liang and Zhen Huo in Science Progress</p

sj-pdf-3-sci-10.1177_00368504231220765 - Supplemental material for A puzzling case report of well-differentiated neuroendocrine tumor mixed with gastric adenocarcinoma of the fundic gland type associated with autoimmune gastritis

Supplemental material, sj-pdf-3-sci-10.1177_00368504231220765 for A puzzling case report of well-differentiated neuroendocrine tumor mixed with gastric adenocarcinoma of the fundic gland type associated with autoimmune gastritis by Zheng Wang, Weixun Zhou, Jingnan Li, Wenlong Wen, Zhiyong Liang and Zhen Huo in Science Progress</p

KRAS ARMS results

KRAS ARMS result

Sanger sequencing

Sanger sequencing for Assay sensitivit

PGM sequencing

PGM sequencing for assay sensitivit

Representative PDAC cases with different EGFR/CXCR4 expression profiles: EGFR-/CXCR4− (A), EGFR+/CXCR4− (B), EGFR-/CXCR4+ (C), and EGFR+/CXCR4+ (D). Magnification x 100.

<p>Representative PDAC cases with different EGFR/CXCR4 expression profiles: EGFR-/CXCR4− (A), EGFR+/CXCR4− (B), EGFR-/CXCR4+ (C), and EGFR+/CXCR4+ (D). Magnification x 100.</p

Univariate analysis for disease-free survival and overall survival.

<p>Univariate analysis for disease-free survival and overall survival.</p

Representative PDAC cases with different EGFR/CXCR4 expression profiles: EGFR-/CXCR4− (A), EGFR+/CXCR4− (B), EGFR-/CXCR4+ (C), and EGFR+/CXCR4+ (D). Magnification x 100.

<p>Representative PDAC cases with different EGFR/CXCR4 expression profiles: EGFR-/CXCR4− (A), EGFR+/CXCR4− (B), EGFR-/CXCR4+ (C), and EGFR+/CXCR4+ (D). Magnification x 100.</p

Additional file 1: Figure S1. of Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma

AREG RNA and protein levels in pancreatic cancer cells and pancreatic stellate cells. A, AREG mRNA levels in pancreatic cancer cells and pancreatic stellate cells. B, AREG protein levels in pancreatic cancer cells and pancreatic stellate cells, * indicates a P < 0.05. (DOC 718 kb

Multivariate analysis for disease-free survival and overall survival.

<p>Multivariate analysis for disease-free survival and overall survival.</p